Bradley Merrill Thompson, a Member of the Firm in the Health Care and Life Sciences practice, in the Washington, DC, office, was quoted in Radiology Business, "CDS a Priority As The Center for Device and Radiological Health Releases 2015 Guidance Plans," by Michael Bassett.
Following is an excerpt:
“It’s progress,” said Bradley Merrill Thompson, an attorney with the firm Epstein, Becker & Green in Washington D.C, who counsels medical device, drug and combination product companies on FDA regulatory, reimbursement, and clinical trial issues. “But it’s exceedingly slow progress.” Thompson pointed out the health IT industry has been urging FDA for years to move on issues like general wellness products, medical device accessories, and interoperability, as well as medical device decision-support software.
“The guidance on medical device decision-support software has been on the agency’s agenda since 2011,” Thompson noted. “It seems to be moving up the agenda — that’s the good news. But it has taken four years and that’s bad news for anyone trying to bring new technology to market.”
